Kunezinhlobo ezintathu ezinkulu zemithi esetshenziselwa ukwelapha i- herpes yomlomo ( izilonda ezibandayo ) ne- herpes yomzimba . Lezi zi-acyclovir, i-valacyclovir, ne-famciclovir. Yonke imithi emithathu ihlukaniswa njengama-anti-viral, futhi anezinto ezifanayo. I-Acyclovir ngumkhiqizo oye wathola isikhathi eside kakhulu. Ngakho-ke, kuningi ubufakazi obukhona ekusekeleni ukwelashwa nalo kunomunye imithi ye-herpes.
Ukusebenzisa Ukwelashwa Ukuqeda Izimpawu
Imithi ye-Herpes ivame ukusetshenziselwa ukunciphisa ukuqubuka nokunciphisa ubukhulu bezimpawu. Ngalesi sizathu, kuyadingeka izifundo ezifushane nje zokwelashwa kwe-herpes. Abantu ngokuvamile imithi ngokushesha nje lapho bezwa izimpawu ze-prodromal . Lezo zimpawu, ezibonisa ukuqala kwesibindi, nazo zibonisa isikhathi esihle sokuqala nge-herpes meds. Ukwelashwa ngomlomo ngokuvamile kuvela ezinsukwini ezingu-5-10. Kodwa-ke, ezinye zokwelapha ezimfushane zikhona.
Ukwelashwa ngomlomo kuhilela ukusetshenziswa kwe-acyclovir, famciclovir, noma i-valacyclovir. Zonke izidakamizwa ezintathu zinezinqubo ezifanayo zesenzo. Noma kunjalo, i-famciclovir ne-valacyclovir ihlelwe ngendlela evumela abantu ukuba babathathe kancane. Kunezimo lapho abantu bazobekwa khona ukuthatha i-acyclovir kaningi izikhathi ezinhlanu ngosuku. Ezinye izidakamizwa zivame ukuthathwa kanye kuphela noma kabili ngosuku.
Ukwelashwa Okuvimbela Iziqhumane
Imithi ye-Herpes ayisetshenziselwa ukuqeda izilonda ezibandayo kanye nezimpawu zomzimba.
Zingasetshenziswa futhi ukuvimbela iziqhumane. Lolu hlobo lwezokwelapha lubizwa ngokuthi ukwelashwa okucindezelayo . Abantu bathatha imishanguzo ye-herpes njalo ukuze kugcinwe amazinga wegciwane egazini labo. Ukwelapha ngokuvamile kuhilela ukusetshenziswa komlomo we-acyclovir, famciclovir, noma i-valacyclovir, njengoba kukhona ubufakazi obuncane bokuthola ukwelashwa kwama-topical.
Ukwelashwa okucindezelayo kwenza kube lula ukuthi ukuqhuma kuzokwenzeka. Futhi kunciphisa amathuba okuthi i-herpes izosabalalisa kumlingani. Ngakho-ke, abanye abantu basebenzisa ukwelashwa okucindezelayo ngisho noma bengenayo ukuqhuma okuvamile. Noma kunjalo, kubalulekile ukukhumbula ukuthi ukudluliselwa kungakwenzeka, ngisho noma ungenaso isiphepho.
Alternative Therapies
Kunezinto eziningi "ezihlukile" noma imikhiqizo yemvelo ekhangiswa njengezokwelapha ze-herpes. Ngokuthakazelisayo, ukwelashwa onokubukeka okungcono kakhulu akuyona into oyodinga ukucabanga. Nakuba i- lysine ivame ukuxoxwa njengokwelashwa kwe-herpes, ubufakazi buhlanganisiwe. Ezinye izifundo zithole imiphumela emihle, kanti abanye abatholanga lutho. Kuyathakazelisa ukuthi kukhona ukwelashwa okunye okunokufakaza okuqhubekayo ... uju . Izakhiwo zayo zemvelo ezilwa namagciwane ezibonakalayo zibonakala zizosiza izimpawu zokuphulukisa. Kunezinyosi eziningana ezikhishwayo (i-propiolis) amafutha atholakala ekusetshenzisweni kwama-topical.
Izikhwama Nezokwelapha Zamafu
Kunezinhlobo eziningi zezokwelapha ze-herpes nokuphulukiswa ngaphandle lapho emakethe. Abantu ababenza bazi ukuthi abantu abane-herpes bavame ukubhekwa kalula. Ukuhlambalaza kwesifo kunzima kakhulu, ukuthi abantu abaningi bazozama noma yini ukuthola ukwelashwa.
Ngenhlanhla, uma wazi ukuthi wenzani, ukuphulukiswa kwama-herpes okukhohlisayo kulula ukubona. Kufanele wazi ukuthi yini oyifunayo .
Ukusobala ukuthi ubufakazi obuningi bokuphulukiswa kwamafake kwenziwa ngabantu bangempela. Kungenxa yokuthi lezi zikhwama kanye nokuphulukiswa kwama-herpes okukhohlisayo kungabonakala sengathi kusebenza uma bengakwenzi nhlobo noma yini. Kanjani? Iningi labantu lithola ukuqhuma okuncane ngokuhamba kwesikhathi. Ukuqubuka kwazo nakho kuba nzima kakhulu. Uma lezo zinto zenzeka ngemuva kokuqala ukuthatha imithi, imithi ingase ibonakale isebenza. Kodwa-ke, isikhathi esiningi, lezo zithuthukisi zizokwenzeka noma kunjalo.
Imithombo:
Cernik C, Gallina K, Brodell RT. Ukwelashwa kwe-herpes simplex ukutheleleka: ukubuyekezwa okusekelwe ebufakazini. I-Arch Intern Med. 2008 Jun 9; 168 (11): 1137-44. i-doi: 10.1001 / archinte.168.11.1137.
Chi CC, Wang SH, Delamere FM, Wojnarowska F, Peters MC, Kanjirath PP. Ukungenelela kokuvikela i-herpes simplex labialis (izilonda ezibandayo ezindebe). I-Cochrane Database Syst Rev. 2015 Aug 7; 8: CD010095.
Corey L, Bodsworth N, Mindel A, Patel R, Schacker T, Stanberry L. Ukubuyekezwa kwesikhashana esifundazweni kanye nokuvimbela izifo zokwelapha ze-herpes genitalis. I-Herpes. 2007 Jun; 14 Ukufaka 1: 5A-11A
Gilbert S, Corey L, Cunningham A, Malkin JE, Stanberry L, Whitley R, Spruance S. Ukubuyekeza ngezikhathi ezincane zokuzivikela kanye nokuvimbela imithi ye-herpes labialis. I-Herpes. 2007 Jun; 14 Uku-1: 13A-18A.
UJohnston C, uSaracino M, Kuntz S, Magaret A, Selke S, Huang ML, Schiffer JT, Koelle DM, Corey L, Wald A. Umthamo we-standard kanye ne-high-dose anti-anti-infiratory treatment for episodes ezincane zokuvuselela ngokocansi HSV-2: izintathu ezintathu ezilandelanayo, ezivuliwe, ukuhlolwa okuphambene. I-Lancet. 2012 Feb 18; 379 (9816): 641-7. i-doi: 10.1016 / S0140-6736 (11) 61750-9.
Le Cleach L, Trinquart L, Do G, Maruani A, Lebrun-Vignes B, Ravaud P, Chosidow O. Ukwelashwa kwemithi elwa namagciwane okuvimbela i-herpes ngokocansi kuqhuma iziguli ezingenakuqhathaniswa nezigameko. I-Cochrane Database Syst Rev. 2014 Aug 3; 8: CD009036. i-doi: 10.1002 / 14651858.CD009036.pub2.
U-Mujugira A, Magaret AS, Celum C, Baeten JM, Lingappa JR, Morrow RA, Fife KH, Delany-Moretlwe S, de Bruyn G, Bukusi EA, Karita E, Kapiga S, Corey L, Wald A; Abalingani ekuvimbeleni iHSV / HIV Team Transmission Team. I-acyclovir yansuku zonke ukunciphisa ukudluliswa kwe-herpes simplex virus type 2 (HSV-2) kusuka kubantu abathintekayo be-HSV-2 / HIV-1: isilingo esilawulwa ngokungahleliwe. I-Disfect Dis Dis. 2013 Nov 1; 208 (9): 1366-74. doi: 10.1093 / infdis / jit333.
Nolkemper S, Reichling J, Sensch KH, Schnitzler P. Umshini we-herpes simplex virus type 2 ukucindezelwa yizicucu ze-propolis. I-Phytomedicine. 2010 Feb; 17 (2): 132-8. doi: 10.1016 / j.phymed.2009.07.006.
Wagh VD. I-Propolis: umkhiqizo omangalisayo wezinyosi kanye namakhono ayo okusebenza kwemithi. Adv Pharmacol Sci. 2013; 2013: 308249. i-doi: 10.1155 / 2013/308249.